Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01196130 · ClinicalTrials.gov registry record
Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening Protocol
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 1,275
- Enrollment target
NCT01196130: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01196130 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,275 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01196130 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 1,275 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to test for biomarkers in patients with metastatic or unresectable, locally advanced colorectal cancer. Biomarkers are chemical "markers" in the tumor tissue and/or blood that may be related to your reaction to cancer drugs. This is an investigational study. This study's biomarker testing is for research purposes only. Up to 1280 patients will be enrolled in this study. All will be enrolled at MD Anderson.
Primary Outcome
Descriptive analysis performed to report the frequency of informative biomarkers for each of the companion allocation biomarkers as a proportion of patients enrolled onto the study. The primary analysis will be number of patients where informative biomarker results were determined for all tested biomarkers divided by the total number of patients enrolled on the study. Results reported separately for each of the individual biomarkers. Reasons for non-informative results reported descriptively.
Interventions
- BEHAVIORAL Cancer Symptom Questionnaire
- OTHER Biomarker Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,275 participants |
| Start Date | 2010-08 |
| Est. Completion | 2022-12-09 |
What the finished NCT01196130 record still lists
NCT01196130 is an observational study that tracks outcomes without assigning an intervention. Its 1,275 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Cancer Symptom Questionnaire is the first listed.
NCT01196130 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01196130 about?
NCT01196130 is a clinical study titled "Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening Protocol". The goal of this clinical research study is to test for biomarkers in patients with metastatic or unresectable, locally advanced colorectal cancer. Biomarkers are chemical "markers" in the tumor tissue and/or blood that may be related to your reaction to cancer drugs. This is an investigational stu...
What is the current status of trial NCT01196130?
This trial is currently completed. The enrollment target is 1,275 participants. The study started on 2010-08. Estimated completion is 2022-12-09.
What interventions are being tested in trial NCT01196130?
The interventions under investigation include: Cancer Symptom Questionnaire (BEHAVIORAL), Biomarker Testing (OTHER).
Who is sponsoring clinical trial NCT01196130?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07225504 · 1,275 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- NCT07001800 · 1,276 participants · Phase 2
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
- NCT03678025 · 1,273 participants · Phase 3
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia